Conference abstract · 17 Jul 2017
Conference abstractPublished 17 Jul 2017
Diagnostic and prognostic markers in Non-Hodgkin 's Lymphoma
Minia University, Egypt
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objectives Establishing diagnostic and prognostic factors are very important in the management of Non-Hodgkin Lymphoma (NHL). Our aim was to evaluate the clinical significance of serum cytokines and immunological markers, in NHL patients for assessing treatment response and prognosis of patients. Methods: Serum EMAP-II, IL-19, IL-10, IL-24, TGF-β, CD3, CD5, CD10, CD19, CD20, CD22, CD23, CD68, CD79a, CD99, LCA, bcl-2, bcl-6 and anticardiolipin (aCA) IgM, aCA IgG, antinulclear antibodies (ANA) levels were measured in the serum of 64 NHL patients before and after treatment with CHOP-based chemotherapy by enzyme-linked immunosorbent assay. Correlations of marker levels to the laboratory, and clinicopathological markers were performed. Results: Serum levels of EMAP-II, IL-10, CD3, CD5, CD10, CD19, CD20, CD99 and aCA IgG were higher before therapy and decreased significantly thereafter (P<0.001). Serum CD68, CD79a and bcl-6 did not change after therapy. Significantly higher levels of IL-19, IL-24, bcl-2, CD22, CD23, LCA, TGF- β, ANA, and aCA IgM were demonstrated in patients with relapse (P<0.001). Significant associations were found between serum markers, clinicopathological and laboratory findings. Conclusion: Cytokines and immunological markers can serve as useful diagnostic markers in NHL patients. They assessed response to therapy. Serum IL-19, IL-24, bcl-2, CD22, CD23, LCA, TGF- β, ANA, and aCA IgM proved to be the most sensitive predictor of advanced disease and poor prognosis
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 29 Jun 2017
Clonality Assessment of B Non-Hodgkin's Lymphoma by Multiparameter Flow Cytometry of Bone Marrow Biopsy: an Additional Diagnostic Tool
Perspective · 4 Apr 2023
Scope of B-Cell Non-Hodgkin Lymphoma Clinical Pathology
Article · 1 Jul 2016
The prognosis factors research on the 172 non-hodgkin lymphoma cases.
Conference abstract · 18 May 2016
Genomic Signatures in non-Hodgkin lymphomas
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectHaematology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Manal Mohamed Saber”
